Skip to main content
Top
Published in: Endocrine Pathology 4/2009

01-12-2009

Microvessel Density and Area in Pituitary Microadenomas

Authors: Ewa Jasek, Alicja Furgal-Borzych, Grzegorz J. Lis, Jan A. Litwin, Ewa Rzepecka-Wozniak, Franciszek Trela

Published in: Endocrine Pathology | Issue 4/2009

Login to get access

Abstract

Microvessel density (MVD) and area (MVA) were assessed in 53 clinically silent pituitary microadenomas and in surrounding normal pituitary tissue using CD34 immunostaining and digital image analysis system. Twenty-one microadenomas (40%) were avascular; in the others, both MVD and MVA were significantly lower than in the normal pituitary tissue. No significant differences in MVD and MVA were found between hormonally immunonegative and immunopositive tumors or between different hormonal subtypes of immunopositive microadenomas. In microadenomas and in normal pituitary tissue, MVD and MVA were not significantly influenced by age or sex. These results suggest that pituitary adenomas at early developmental stage are either avascular or significantly less vascular than normal pituitary tissue and that differences in vascularity of pituitary adenomas associated with the variables of sex, age, clinical presentation and immunohistochemical phenotype reported in the literature can evolve with tumor growth and possibly acquire statistical significance in large macroadenomas.
Literature
1.
go back to reference Nico B, Benagiano V, Mangieri D, Maruotti N, Vacca A, Ribatti D. Evaluation of microvascular density in tumors: pro and contra. Histol Histopathol 23:601–607, 2008.PubMed Nico B, Benagiano V, Mangieri D, Maruotti N, Vacca A, Ribatti D. Evaluation of microvascular density in tumors: pro and contra. Histol Histopathol 23:601–607, 2008.PubMed
2.
go back to reference Góth MI, Hubina E, Raptis S, Nagy GM, Tóth BE. Physiological and pathological angiogenesis in the endocrine system. Microsc Res Tech 60:98–106, 2003.CrossRefPubMed Góth MI, Hubina E, Raptis S, Nagy GM, Tóth BE. Physiological and pathological angiogenesis in the endocrine system. Microsc Res Tech 60:98–106, 2003.CrossRefPubMed
3.
go back to reference Turner HE, Harris AL, Melmed S, Wass JA. Angiogenesis in endocrine tumors. Endocr Rev 24:600–632, 2003.CrossRefPubMed Turner HE, Harris AL, Melmed S, Wass JA. Angiogenesis in endocrine tumors. Endocr Rev 24:600–632, 2003.CrossRefPubMed
4.
go back to reference Schechter J. Ultrastructural changes in the capillary bed of human pituitary tumors. Am J Pathol 67:109–126, 1972.PubMed Schechter J. Ultrastructural changes in the capillary bed of human pituitary tumors. Am J Pathol 67:109–126, 1972.PubMed
5.
go back to reference Turner HE, Nagy Z, Gatter KC, Esiri MM, Harris AH, Wass JAH. Angiogenesis in pituitary adenomas and the normal pituitary gland. J Clin Endocrinol Metab 85:1159–1162, 2000.CrossRefPubMed Turner HE, Nagy Z, Gatter KC, Esiri MM, Harris AH, Wass JAH. Angiogenesis in pituitary adenomas and the normal pituitary gland. J Clin Endocrinol Metab 85:1159–1162, 2000.CrossRefPubMed
6.
go back to reference Takada K, Yamada S, Teramoto A. Correlation between tumor vascularity and clinical findings in patients with pituitary adenomas. Endocr Pathol 15:131–140, 2004.CrossRefPubMed Takada K, Yamada S, Teramoto A. Correlation between tumor vascularity and clinical findings in patients with pituitary adenomas. Endocr Pathol 15:131–140, 2004.CrossRefPubMed
7.
go back to reference Vidal S, Kovacs K, Horvath E, Scheithauer BW, Kuroki T, Lloyd RV. Microvessel density in pituitary adenomas and carcinomas. Virchows Arch 438:595–602, 2001.CrossRefPubMed Vidal S, Kovacs K, Horvath E, Scheithauer BW, Kuroki T, Lloyd RV. Microvessel density in pituitary adenomas and carcinomas. Virchows Arch 438:595–602, 2001.CrossRefPubMed
8.
go back to reference Jugenburg M, Kovacs K, Stefaneanu L, Scheithauer BW. Vasculature in nontumorous hypophyses, pituitary adenomas, and carcinomas: a quantitative morphological study. Endocr Pathol 6:115–124, 1995.CrossRefPubMed Jugenburg M, Kovacs K, Stefaneanu L, Scheithauer BW. Vasculature in nontumorous hypophyses, pituitary adenomas, and carcinomas: a quantitative morphological study. Endocr Pathol 6:115–124, 1995.CrossRefPubMed
9.
go back to reference Viacava P, Bocci G, Fanelli G et al. Microvessel density in human normal and neoplastic parathyroids. Endocr Pathol 17:175–181, 2006.CrossRefPubMed Viacava P, Bocci G, Fanelli G et al. Microvessel density in human normal and neoplastic parathyroids. Endocr Pathol 17:175–181, 2006.CrossRefPubMed
10.
go back to reference de la Torre NG, Buley I, Wass JA, Jackson DG, Turner HE. Angiogenesis and lymphangiogenesis in parathyroid proliferative lesions. J Clin Endocrinol Metab 89:2890–2896, 2004.CrossRef de la Torre NG, Buley I, Wass JA, Jackson DG, Turner HE. Angiogenesis and lymphangiogenesis in parathyroid proliferative lesions. J Clin Endocrinol Metab 89:2890–2896, 2004.CrossRef
11.
go back to reference de la Torre NG, Buley I, Wass JA, Turner HE. Angiogenesis and lymphangiogenesis in thyroid proliferative lesions: relationship to type and tumour behaviour. Endocr Relat Cancer 13:931–944, 2006.CrossRefPubMed de la Torre NG, Buley I, Wass JA, Turner HE. Angiogenesis and lymphangiogenesis in thyroid proliferative lesions: relationship to type and tumour behaviour. Endocr Relat Cancer 13:931–944, 2006.CrossRefPubMed
12.
go back to reference Jebreel A, England J, Bedford K, Murphy J, Karsai L, Atkin S. Vascular endothelial growth factor (VEGF), VEGF receptors expression and microvascular density in benign and malignant thyroid diseases. Int J Exp Pathol 88:271–277, 2007.CrossRefPubMed Jebreel A, England J, Bedford K, Murphy J, Karsai L, Atkin S. Vascular endothelial growth factor (VEGF), VEGF receptors expression and microvascular density in benign and malignant thyroid diseases. Int J Exp Pathol 88:271–277, 2007.CrossRefPubMed
13.
go back to reference Sasano H, Ohashi Y, Suzuki T, Nagura H. Vascularity in human adrenal cortex. Mod Pathol 11:329–333, 1998.PubMed Sasano H, Ohashi Y, Suzuki T, Nagura H. Vascularity in human adrenal cortex. Mod Pathol 11:329–333, 1998.PubMed
14.
go back to reference Poncelet C, Madelenat P, Feldmann G, Walker F, Darai E. Expression of von Willebrand’s factor, CD34, CD31, and vascular endothelial growth factor in uterine leiomyomas. Fertil Steril 78:581–586, 2002.CrossRefPubMed Poncelet C, Madelenat P, Feldmann G, Walker F, Darai E. Expression of von Willebrand’s factor, CD34, CD31, and vascular endothelial growth factor in uterine leiomyomas. Fertil Steril 78:581–586, 2002.CrossRefPubMed
15.
go back to reference Couvelard A, O’Toole D, Turley H et al. Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression. Br J Cancer 92:94–101, 2005.CrossRefPubMed Couvelard A, O’Toole D, Turley H et al. Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression. Br J Cancer 92:94–101, 2005.CrossRefPubMed
16.
go back to reference Kakolyris SA., Kaklamanis LG, Koukourakis MJ et al. Angiogenesis and p53 expression in the colorectal adenoma – carcinoma sequence. Oncol Res 12:203–208, 2000.PubMed Kakolyris SA., Kaklamanis LG, Koukourakis MJ et al. Angiogenesis and p53 expression in the colorectal adenoma – carcinoma sequence. Oncol Res 12:203–208, 2000.PubMed
17.
go back to reference Turner HE, Nagy Z, Gatter KC, Esiri MM, Harris AL. Angiogenesis in pituitary adenomas – relationship to endocrine function, treatment and outcome. J Endocrinol 165:475–481, 2000.CrossRefPubMed Turner HE, Nagy Z, Gatter KC, Esiri MM, Harris AL. Angiogenesis in pituitary adenomas – relationship to endocrine function, treatment and outcome. J Endocrinol 165:475–481, 2000.CrossRefPubMed
18.
go back to reference Pizarro CB, Oliveira MC, Pereira-Lima JFS et al. Evaluation of angiogenesis in 77 pituitary adenomas using endoglin as a marker. Neuropathology 29:40–44, 2008.CrossRefPubMed Pizarro CB, Oliveira MC, Pereira-Lima JFS et al. Evaluation of angiogenesis in 77 pituitary adenomas using endoglin as a marker. Neuropathology 29:40–44, 2008.CrossRefPubMed
19.
go back to reference Pawlikowski M, Pisarek H, Jaranowska M. Immunocytochemical investigations on the vascularization of pituitary adenomas. Endocr Pathol 8:189–193, 1997.CrossRefPubMed Pawlikowski M, Pisarek H, Jaranowska M. Immunocytochemical investigations on the vascularization of pituitary adenomas. Endocr Pathol 8:189–193, 1997.CrossRefPubMed
20.
go back to reference Buurman H, Saeger W. Subclinical adenomas in postmortem pituitaries: classification and correlation to clinical data. Eur J Endocrinol 5:753–758, 2006.CrossRef Buurman H, Saeger W. Subclinical adenomas in postmortem pituitaries: classification and correlation to clinical data. Eur J Endocrinol 5:753–758, 2006.CrossRef
21.
go back to reference Poblet E, Gonzales-Palacios F, Jimenez FJ. Different immunoreactivity of endothelial markers in well and poorly differentiated areas of angiosarcomas. Virchows Arch 428:217–221, 1996.CrossRefPubMed Poblet E, Gonzales-Palacios F, Jimenez FJ. Different immunoreactivity of endothelial markers in well and poorly differentiated areas of angiosarcomas. Virchows Arch 428:217–221, 1996.CrossRefPubMed
22.
go back to reference Yao X, Qian CN, Zhang ZF et al. Two distinct types of blood vessels in clear cell renal cell carcinoma have contrasting prognostic implications. Clin Cancer Res 13:161–169, 2007.CrossRefPubMed Yao X, Qian CN, Zhang ZF et al. Two distinct types of blood vessels in clear cell renal cell carcinoma have contrasting prognostic implications. Clin Cancer Res 13:161–169, 2007.CrossRefPubMed
23.
go back to reference Pusztaszeri MP, Seelentag W, Bosman FT. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem 54:385–395, 2006CrossRefPubMed Pusztaszeri MP, Seelentag W, Bosman FT. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem 54:385–395, 2006CrossRefPubMed
24.
go back to reference Walocha JA, Litwin JA, Miodoński AJ. Vascular system of intramural leiomyomata revealed by corrosion casting and scanning electron microscopy Hum Reprod 18:1088–1093, 2003. Walocha JA, Litwin JA, Miodoński AJ. Vascular system of intramural leiomyomata revealed by corrosion casting and scanning electron microscopy Hum Reprod 18:1088–1093, 2003.
25.
go back to reference Holash J, Wiegand SJ, Yancopoulos GD. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18:5356–5362, 1999.CrossRefPubMed Holash J, Wiegand SJ, Yancopoulos GD. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18:5356–5362, 1999.CrossRefPubMed
26.
go back to reference Itoh J, Serizava A, Kawai K, Ishii Y, Teramoto A, Osamura RY. Vascular networks and endothelial cells in the rat experimental pituitary glands and in human pituitary adenomas. Microsc Res Tech 60:231–235, 2003CrossRefPubMed Itoh J, Serizava A, Kawai K, Ishii Y, Teramoto A, Osamura RY. Vascular networks and endothelial cells in the rat experimental pituitary glands and in human pituitary adenomas. Microsc Res Tech 60:231–235, 2003CrossRefPubMed
27.
go back to reference Ho DMT, Hsu CY, Ting LT, Chiang H. Plurihormonal pituitary adenomas: immunostaining of all pituitary hormones is mandatory for correct classification. Histopathology 39:310–319, 2001CrossRefPubMed Ho DMT, Hsu CY, Ting LT, Chiang H. Plurihormonal pituitary adenomas: immunostaining of all pituitary hormones is mandatory for correct classification. Histopathology 39:310–319, 2001CrossRefPubMed
28.
go back to reference Holck S, Klinken L. Entrapped, non-neoplastic adenohypophysiocytes in human pituitary adenomas. Clin Neuropathol 9:251–253, 1990.PubMed Holck S, Klinken L. Entrapped, non-neoplastic adenohypophysiocytes in human pituitary adenomas. Clin Neuropathol 9:251–253, 1990.PubMed
29.
go back to reference Kleinschmidt-DeMasters BK. Immunohistochemistry of pituitary adenomas. In: Wierman ME, ed. Diseases of the pituitary: diagnosis and treatment. Contemporary Endocrinology. Totowa, NJ: Humana, 1997; 377–393. Kleinschmidt-DeMasters BK. Immunohistochemistry of pituitary adenomas. In: Wierman ME, ed. Diseases of the pituitary: diagnosis and treatment. Contemporary Endocrinology. Totowa, NJ: Humana, 1997; 377–393.
30.
go back to reference Niveiro M, Aranda FI, Peiro G, Alenda C, Pico A. Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas. Hum Pathol 36:1090–1095, 2005.CrossRefPubMed Niveiro M, Aranda FI, Peiro G, Alenda C, Pico A. Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas. Hum Pathol 36:1090–1095, 2005.CrossRefPubMed
Metadata
Title
Microvessel Density and Area in Pituitary Microadenomas
Authors
Ewa Jasek
Alicja Furgal-Borzych
Grzegorz J. Lis
Jan A. Litwin
Ewa Rzepecka-Wozniak
Franciszek Trela
Publication date
01-12-2009
Publisher
Humana Press Inc
Published in
Endocrine Pathology / Issue 4/2009
Print ISSN: 1046-3976
Electronic ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-009-9091-1

Other articles of this Issue 4/2009

Endocrine Pathology 4/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.